C 881

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 597626

CAS#: 75106-53-5

Description: C 881 is a raw testosterone propionate material.

Chemical Structure

C 881
CAS# 75106-53-5

Theoretical Analysis

MedKoo Cat#: 597626
Name: C 881
CAS#: 75106-53-5
Chemical Formula: C20H22ClN3O4S
Exact Mass:
Molecular Weight: 435.92
Elemental Analysis: C, 55.11; H, 5.09; Cl, 8.13; N, 9.64; O, 14.68; S, 7.35

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: C 881; C-881; C881;

IUPAC/Chemical Name: ethyl (1-nitroacridin-9-yl)-L-methioninate hydrochloride


InChi Code: InChI=1S/C20H21N3O4S.ClH/c1-3-27-20(24)16(11-12-28-2)22-19-13-7-4-5-8-14(13)21-15-9-6-10-17(18(15)19)23(25)26;/h4-10,16H,3,11-12H2,1-2H3,(H,21,22);1H/t16-;/m0./s1

SMILES Code: CSCC[C@@H](C(OCC)=O)NC1=C(C([N+]([O-])=O)=CC=C2)C2=NC3=CC=CC=C31.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

Preparing Stock Solutions

The following data is based on the product molecular weight 435.92 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Crawford EF, Fulton JJ, Swinkels CM, Beckham JC; VA Mid-Atlantic MIRECC OEF/OIF Registry Workgroup, Calhoun PS. Diagnostic efficiency of the AUDIT-C in U.S. veterans with military service since September 11, 2001. Drug Alcohol Depend. 2013 Sep 1;132(1-2):101-6. doi: 10.1016/j.drugalcdep.2013.01.012. Epub 2013 Mar 7. PubMed PMID: 23465735.

2: Slinin Y, Peters KW, Ishani A, Yaffe K, Fink HA, Stone KL, Steffes M, Ensrud KE; Study of Osteoporotic Fractures. Cystatin C and cognitive impairment 10 years later in older women. J Gerontol A Biol Sci Med Sci. 2015 Jun;70(6):771-8. doi: 10.1093/gerona/glu189. Epub 2014 Nov 1. PubMed PMID: 25362662; PubMed Central PMCID: PMC4447803.

3: Enokida Y, Shimizu K, Kakegawa S, Atsumi J, Takase Y, Miyamae Y, Nagashima T, Ohtaki Y, Kaira K, Sunaga N, Yanagitani N, Yoshino R, Tsunekawa K, Igai H, Kamiyoshihara M, Usui K, Lezhava A, Tomizawa Y, Ishikawa T, Murakami M, Hayashizaki Y, Takeyoshi I. Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk. Biomed Rep. 2014 Sep;2(5):719-724. Epub 2014 Jun 26. PubMed PMID: 25054017; PubMed Central PMCID: PMC4106610.

4: Zhan X, Lin N, Zhang HW, Gao XL, Qiu WJ, Han LS, Ye J, Gu XF. [Blood 7-ketocholesterol level, clinical features and gene mutation analysis of 18 children with Niemann-Pick disease type C]. Zhonghua Er Ke Za Zhi. 2016 Jun 2;54(6):419-23. doi: 10.3760/cma.j.issn.0578-1310.2016.06.006. Chinese. PubMed PMID: 27256227.

5: Hutchinson J, Lentjes MA, Greenwood DC, Burley VJ, Cade JE, Cleghorn CL, Threapleton DE, Key TJ, Cairns BJ, Keogh RH, Dahm CC, Brunner EJ, Shipley MJ, Kuh D, Mishra G, Stephen AM, Bhaniani A, Borgulya G, Khaw KT. Vitamin C intake from diary recordings and risk of breast cancer in the UK Dietary Cohort Consortium. Eur J Clin Nutr. 2012 May;66(5):561-8. doi: 10.1038/ejcn.2011.197. Epub 2011 Nov 30. PubMed PMID: 22127331; PubMed Central PMCID: PMC3378489.

6: Baumeister D, Akhtar R, Ciufolini S, Pariante CM, Mondelli V. Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α. Mol Psychiatry. 2016 May;21(5):642-9. doi: 10.1038/mp.2015.67. Epub 2015 Jun 2. PubMed PMID: 26033244; PubMed Central PMCID: PMC4564950.

7: Maruniak-Chudek I, Owsianka-Podleśny T, Wróblewska J, Jadamus-Niebrój D. Is serum cystatin C a better marker of kidney function than serum creatinine in septic newborns? Postepy Hig Med Dosw (Online). 2012 Apr 2;66:175-80. PubMed PMID: 22470193.

8: Paterna S, Fasullo S, Parrinello G, Cannizzaro S, Basile I, Vitrano G, Terrazzino G, Maringhini G, Ganci F, Scalzo S, Sarullo FM, Cice G, Di Pasquale P. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). Am J Med Sci. 2011 Jul;342(1):27-37. doi: 10.1097/MAJ.0b013e31820f10ad. PubMed PMID: 21701268.

9: Akter S, Nanri A, Yi S, Pham NM, Kurotani K, Kimura Y, Matsushita Y, Mizoue T. Dietary patterns and C-peptide concentrations in a Japanese working population. Nutrition. 2012 Sep;28(9):e29-35. doi: 10.1016/j.nut.2012.01.018. Epub 2012 Jun 5. PubMed PMID: 22677358.

10: Mason AB, Allen KE, Slayman CW. C-terminal truncations of the Saccharomyces cerevisiae PMA1 H+-ATPase have major impacts on protein conformation, trafficking, quality control, and function. Eukaryot Cell. 2014 Jan;13(1):43-52. doi: 10.1128/EC.00201-13. Epub 2013 Nov 1. PubMed PMID: 24186948; PubMed Central PMCID: PMC3910955.

11: Yin YW, Sun QQ, Zhang BB, Hu AM, Wang Q, Liu HL, Hou ZZ, Zeng YH, Xu RJ, Shi LB. The lack of association between interleukin-6 gene -174 G/C polymorphism and the risk of type 1 diabetes mellitus: a meta-analysis of 18,152 subjects. Gene. 2013 Feb 25;515(2):461-5. doi: 10.1016/j.gene.2012.11.062. Epub 2012 Dec 13. PubMed PMID: 23246692.

12: Inazumi H, Koyama S, Tanada Y, Fujiwara H, Takatsu Y, Sato Y. Prognostic significance of changes in cystatin C during treatment of acute cardiac decompensation. J Cardiol. 2016 Jan;67(1):98-103. doi: 10.1016/j.jjcc.2015.04.014. Epub 2015 Jun 15. PubMed PMID: 26088298.

13: Li W, Wu H, Song C. TGF-β1 -509C/T (or +869T/C) polymorphism might be not associated with hepatocellular carcinoma risk. Tumour Biol. 2013 Oct;34(5):2675-81. doi: 10.1007/s13277-013-0818-8. Epub 2013 May 8. Retraction in: Tumour Biol. 2017 Apr 20;:. PubMed PMID: 23653379.

14: Bex A, van der Veldt AA, Boven E, Haanen JB. Re: Surgical resection of renal cell carcinoma after targeted therapyA. A. Thomas, B. I. Rini, A. J. Stephenson, J. A. Garcia, A. Fergany, V. Krishnamurthi, A. C. Novick, I. S. Gill, E. A. Klein, M. Zhou and S. C. Campbell J Urol 2009; 182: 881-886. J Urol. 2010 Apr;183(4):1646-7; author reply 1647. doi: 10.1016/j.juro.2009.12.047. Epub 2010 Feb 21. PubMed PMID: 20176381.

15: Zhou B, Shu B, Yang J, Liu J, Xi T, Xing Y. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis. Cancer Causes Control. 2014 Oct;25(10):1397-405. doi: 10.1007/s10552-014-0445-8. Epub 2014 Jul 23. Review. PubMed PMID: 25053407.

16: Gabrikova D, Bernasovska J, Sokolova J, Stiburkova B. High frequency of SLC22A12 variants causing renal hypouricemia 1 in the Czech and Slovak Roma population; simple and rapid detection method by allele-specific polymerase chain reaction. Urolithiasis. 2015 Oct;43(5):441-5. doi: 10.1007/s00240-015-0790-4. Epub 2015 Jun 2. PubMed PMID: 26033041.

17: Wen D, Liu J, Du X, Dong JZ, Ma CS. Association of interleukin-18 (-137G/C) polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Int Rev Immunol. 2014 Jan;33(1):34-44. doi: 10.3109/08830185.2013.816699. Epub 2013 Aug 5. Review. Erratum in: Int Rev Immunol. 2014 Jan;33(1):44. PubMed PMID: 23914907.

18: Yazdanpanahi N, Tabatabaiefar MA, Bagheri N, Azadegan Dehkordi F, Farrokhi E, Hashemzadeh Chaleshtori M. The role and spectrum of SLC26A4 mutations in Iranian patients with autosomal recessive hereditary deafness. Int J Audiol. 2015 Feb;54(2):124-30. doi: 10.3109/14992027.2014.944276. Epub 2014 Oct 7. PubMed PMID: 25290043.

19: Mora S, Caulfield MP, Wohlgemuth J, Chen Z, Superko HR, Rowland CM, Glynn RJ, Ridker PM, Krauss RM. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial. Circulation. 2015 Dec 8;132(23):2220-9. doi: 10.1161/CIRCULATIONAHA.115.016857. Epub 2015 Sep 25. PubMed PMID: 26408274; PubMed Central PMCID: PMC4674425.

20: Luo Y, Fu SJ, She DL, Xiong HU, Yang LI. Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis. Mol Clin Oncol. 2015 Jul;3(4):924-928. Epub 2015 Apr 24. PubMed PMID: 26171208; PubMed Central PMCID: PMC4486906.